ArticleBiomedical chromatography : BMC2026
Study on the Warm Property Mechanism of Pro- HS and Its Separated Fractions Based on Metabolomics.
Article in Biomedical chromatography : BMC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The theory of medicinal properties of traditional Chinese medicine is the core guideline for syndrome differentiation and medication. Herba Siegesbeckiae (HS) is cold in property, and its medicinal property changes from cold to warm after processing. Based on metabolomics technology, this study investigates the regulatory effects of processed HS (pro- HS) and its separated fractions on the neuro-endocrine-metabolic network in cold syndrome rats, aiming to clarify the characteristics associated with medicinal properties. Chemical separation techniques were employed to isolate the main chemical components of pro-HS. A cold syndrome rat model was established via ice water stimulation. Differential expression metabolites (DEMs) and key metabolic pathways were screened by metabolomics, and combined ELISA technology to detect neuro-endocrine-metabolic-related indicators. A total of 48 DEMs were identified, involving 11 core metabolic pathways. Pro-HS and its diterpenoid fraction exerted regulatory effects on the abnormal neurotransmitters, thyroid hormones, and energy metabolism enzyme activities in cold syndrome rats. The pro-HS and its separated fractions exert targeted regulatory effects on metabolic disorders in cold syndrome rats. The mechanism is closely associated with the regulation of the neuro-endocrine-energy metabolism network and related metabolic pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.